160 related articles for article (PubMed ID: 9035104)
21. [Myasthenia gravis].
Storm-Mathisen A
Tidsskr Nor Laegeforen; 1992 May; 112(12):1574-8. PubMed ID: 1615507
[TBL] [Abstract][Full Text] [Related]
22. The pathogenesis of myasthenia gravis.
Fulpius BW
Bull Schweiz Akad Med Wiss; 1978 Mar; 34(1-3):25-31. PubMed ID: 667413
[TBL] [Abstract][Full Text] [Related]
23. [Structure of receptors and expression of anti-receptor antibodies. b. Anti-acetylcholine receptor antibodies].
Takamori M; Okumura S; Nagata M
Nihon Rinsho; 1988 Apr; 46(4):816-21. PubMed ID: 3261359
[No Abstract] [Full Text] [Related]
24. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
[TBL] [Abstract][Full Text] [Related]
25. An indirect immunofluorescence test for the detection of acetylcholine receptor antibodies.
Anlar B; Sungur A; Ruacan S; Imir T
Muscle Nerve; 1993 Nov; 16(11):1266-7. PubMed ID: 8413382
[No Abstract] [Full Text] [Related]
26. Antibodies to the acetylcholine receptor molecule and its component polypeptide chains.
Lindstrom J
Adv Cytopharmacol; 1979; 3():245-53. PubMed ID: 89802
[No Abstract] [Full Text] [Related]
27. [Heterogeneity of antibodies blocking the binding of bungarotoxin to the acetylcholine receptor in myasthenia].
Vernet-der-Garabédian B; Morel E; Bach JF
C R Acad Sci III; 1984; 298(16):449-56. PubMed ID: 6428718
[TBL] [Abstract][Full Text] [Related]
28. Acetylcholine receptors and myasthenia gravis: the effect of antibodies to eel acetylcholine receptors on eel electric organ cells.
Lindstrom J; Einarson B; Francy M
Prog Clin Biol Res; 1977; 15():119-30. PubMed ID: 928444
[TBL] [Abstract][Full Text] [Related]
29. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
[TBL] [Abstract][Full Text] [Related]
30. [Pathogenic mechanisms of myasthenia gravis induced by antibodies against muscle-specific kinase].
Maruyama N; Shigemoto K
Rinsho Shinkeigaku; 2007 Nov; 47(11):842-4. PubMed ID: 18210813
[TBL] [Abstract][Full Text] [Related]
31. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
32. [Acetylcholine receptors and myasthenia gravis].
Yagi K; Uono M
Nihon Rinsho; 1979; 37(8):3115-24. PubMed ID: 390183
[No Abstract] [Full Text] [Related]
33. [Measurement of anti-acetylcholine receptor antibody using human rhabdomyosarcoma cell line].
Ito R; Ishiguro Y; Tetsumoto T; Harada H; Takanashi N; Oka M; Shindo Y; Yamauchi S; Ishigami T; Ohta K
Rinsho Byori; 1995 Apr; 43(4):402-8. PubMed ID: 7739124
[TBL] [Abstract][Full Text] [Related]
34. Treatment of myasthenia gravis by preventing acetylcholine receptor modulation.
Losen M; Martínez-Martínez P; Phernambucq M; Schuurman J; Parren PW; De Baets MH
Ann N Y Acad Sci; 2008; 1132():174-9. PubMed ID: 18567867
[TBL] [Abstract][Full Text] [Related]
35. Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors.
Lennon VA; Lambert EH
Nature; 1980 May; 285(5762):238-40. PubMed ID: 6154894
[No Abstract] [Full Text] [Related]
36. [Anesthetic considerations for thymectomy in a patient having an anti-acetylcholine receptor antibody without myasthenia gravis].
Koshida T; Hara K; Obara G; Sata T
Masui; 2008 Aug; 57(8):993-5. PubMed ID: 18710007
[TBL] [Abstract][Full Text] [Related]
37. A lipid-associated acetylcholine receptor as an antigen in diagnosis of myasthenia gravis.
Raimond F; Vernet-der-Garabedian B; Morel E
Clin Exp Immunol; 1982 Feb; 47(2):345-50. PubMed ID: 7075027
[TBL] [Abstract][Full Text] [Related]
38. Classification of myasthenia gravis based on autoantibody status.
Suzuki S; Utsugisawa K; Nagane Y; Satoh T; Terayama Y; Suzuki N; Kuwana M
Arch Neurol; 2007 Aug; 64(8):1121-4. PubMed ID: 17698702
[TBL] [Abstract][Full Text] [Related]
39. Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis.
Zisimopoulou P; Lagoumintzis G; Kostelidou K; Bitzopoulou K; Kordas G; Trakas N; Poulas K; Tzartos SJ
J Neuroimmunol; 2008 Sep; 201-202():95-103. PubMed ID: 18667243
[TBL] [Abstract][Full Text] [Related]
40. Antigen-specific apheresis of pathogenic autoantibodies from myasthenia gravis sera.
Tzartos SJ; Bitzopoulou K; Gavra I; Kordas G; Jacobson L; Kostelidou K; Lagoumintzis G; Lazos O; Poulas K; Sideris S; Sotiriadis A; Trakas N; Zisimopoulou P
Ann N Y Acad Sci; 2008; 1132():291-9. PubMed ID: 18567880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
